Robert Trenschel SEC EDGAR Filings (CIK 0001849917)

SEC EDGAR filings, ownership reports, and insider transactions for Robert Trenschel.

Business address
C/O Seneca Biopharma, Inc., 20271 Goldenrod Lane, Germantown, MD, 20876
Top holdings (ownership)
PALI
Get insider transactions for this reporting owner
Robert Trenschel has filed 8 SEC EDGAR filings since 29 Apr 2021

Latest Filings

Recent SEC filings for Robert Trenschel including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 13 Feb 2024 08 Feb 2024 001-33672
4 Open 4 document View SEC filing for 4 24 Nov 2023 21 Nov 2023 001-33672
4 Open 4 document View SEC filing for 4 15 Sep 2023 14 Sep 2023 001-33672
4 Open 4 document View SEC filing for 4 13 Jun 2023 11 Jun 2023 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Feb 2022 18 Nov 2021 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Sep 2021 31 Aug 2021 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 29 Apr 2021 27 Apr 2021 001-33672
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 29 Apr 2021 27 Apr 2021 001-33672

About this filer

Robert Trenschel files with the SEC under CIK 0001849917. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages